MARCY-L’ETOILE, France (Reuters) – France’s president and top drugmaker announced plans on Tuesday to bolster domestic production of medicines as countries scramble to strengthen their healthcare industries to counter the coronavirus pandemic. Drugmaker Sanofi, which is working on two potential coronavirus vaccines, said it would invest 610 million euros ($679 million) at two French sites to turn them into a hub dedicated to research, development and production of vaccines. Speaking at the Marcy-L’Etoile facility, President Emmanuel Macron also pledged 200 million euros to help domestic research and manufacturing of medicines and said his government would announce plans on Thursday to bring back some drug production facilities to France.
